Approaches to spatially resolving the tumour immune microenvironment of hepatocellular carcinoma. (July 2022)

• Record Type: Journal Article
• Authors: Marsh-Wakefield, Felix; Ferguson, Angela L; Liu, Ken; Santhakumar, Cositha; McCaughan, Geoffrey; Palendira, Umaimainthan
• Is Part Of: Therapeutic advances in medical oncology. Volume 14(2022)
• Publication Date: 2022-07
• Subjects: hepatocellular carcinoma -- histopathology -- immunohistochemistry -- transcriptomics -- tumour microenvironment; Oncology -- Periodicals; Cancer -- Treatment -- Periodicals; 616.994005
• DOI: 10.1177/17588359221113270
• Languages: English
• ISSNs: 1758-8340

Abstract

Hepatocellular carcinoma (HCC) is a common and deadly cancer worldwide. Many factors contribute to mortality and place an individual at high risk of developing HCC, including viral infection, alcohol intake, metabolic-associated disease, autoimmunity and genetic liver disorders. Although there are many therapeutics available, much about this disease remains to be understood. This is most evident when investigating the tumour microenvironment (TME). Both innate and adaptive immune cells have been associated with carcinogenesis within the TME of HCC patients. The ability to interrogate the TME more thoroughly with spatial technologies continues to improve, both at the experimental and analytical stages. This review provides insight into technologies available to investigate the TME, and how such technologies are beneficial for improving our understanding of HCC carcinogenesis.